CA 2024 * | 60,47 Md 54,39 Md | CA 2025 * | 62,71 Md 56,41 Md | Capitalisation | 159 Md 143 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 7,28 Md 6,55 Md | Résultat net 2025 * | 10,81 Md 9,72 Md | VE / CA 2024 * | 3,6 x |
Dette nette 2024 * | 59,14 Md 53,2 Md | Dette nette 2025 * | 54,22 Md 48,78 Md | VE / CA 2025 * | 3,39 x |
PER 2024 * |
20,6
x | PER 2025 * |
14,1
x | Employés | - |
Rendement 2024 * |
5,97% | Rendement 2025 * |
6,09% | Flottant | 59,05% |
Dernier transcript sur Pfizer Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 01/01/93 |
David Denton
DFI | Director of Finance/CFO | 59 | 02/05/22 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 66 | 01/04/20 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 23/02/17 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 27/09/13 |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
STRATÉGIE SANTÉ | Non | 2.34M EUR | -3,00% | |
SG ACTIONS MONDE SÉLECTION C | Non | 5M EUR | +12,00% | |
AMUNDI FDS PIO GLOBAL EQUITY A EUR C | Non | 59.29M EUR | +12,00% | |
AXAWF II NORTH AMERICAN EQS A DIS USD | Non | 4.74M USD | +15,00% | |
LIONTRUST GF TORTOISE R EURH | Non | 8.58M EUR | +7,00% |
Varia. 1 janv. | Capi. | |
---|---|---|
+55,32% | 815 Md | |
+44,05% | 641 Md | |
-6,75% | 352 Md | |
+13,56% | 314 Md | |
+10,68% | 303 Md | |
+16,57% | 242 Md | |
+2,04% | 224 Md | |
+13,31% | 218 Md | |
+8,48% | 168 Md |